The Partners of ESP Equity have been working together in an entrepreneuring environment for the last 7 years and most recently build a specialty pharma company from zero to $ 100MM in revenue and sold for more than $500 MM dollars. We are entrepreneur-turned investors and understand opportunity, timing and the needs of entrepreneurs at different stages of the company development.
 
We work closely with exceptional local management teams to acquire pharmaceutical and medical assets to achieve strategic build-up in selected therapeutic areas. We focus on the immediate revenue and cash generating capabilities, the rapid establishment of lead position in niche markets, and cross boarder value/opportunity arbitrages that were overlooked or unreachable by traditional healthcare investors.
 
We leverage our extensive global pharmaceutical contacts and operating experiences in general management, manufacturing, sales and marketing to build value together with entrepreneurs around the world.